Ocular Therapeutix (OCUL) Misses Q2 EPS by 8c

Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.64), $0.08 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $438 thousand versus the consensus estimate of $490 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright
• Carnival shares drop despite earnings beat on weak guidance
• Creatd files Form S-1 and reports Q1 2026 financial results